Literature DB >> 23094259

Primary adenocarcinoma of the lacrimal gland.

Sang-Oon Baek1, Yoon-Jae Lee, Suk-Ho Moon, Young-Jin Kim, Young-Joon Jun.   

Abstract

Entities:  

Year:  2012        PMID: 23094259      PMCID: PMC3474421          DOI: 10.5999/aps.2012.39.5.578

Source DB:  PubMed          Journal:  Arch Plast Surg        ISSN: 2234-6163


× No keyword cloud information.
  5 in total

1.  Adenocarcinoma of the lacrimal gland: report of a case.

Authors:  Luigi Clauser; Manlio Galiè; Riccardo Tieghi; Luigi Cavazzini
Journal:  J Oral Maxillofac Surg       Date:  2002-03       Impact factor: 1.895

2.  Primary ductal adenocarcinoma of the lacrimal gland: case report.

Authors:  Renato Wendell Ferreira Damasceno; Leonard M Holbach
Journal:  Arq Bras Oftalmol       Date:  2012 Jan-Feb       Impact factor: 0.872

3.  Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland.

Authors:  M L Meldrum; D T Tse; P Benedetto
Journal:  Arch Ophthalmol       Date:  1998-03

4.  Surgical management of malignant tumors of the lacrimal gland.

Authors:  I Janecka; E Housepian; S Trokel; R Rankow; I Jones; F Jakobiec
Journal:  Am J Surg       Date:  1984-10       Impact factor: 2.565

Review 5.  Epithelial tumors of the lacrimal gland: an update.

Authors:  Francesco P Bernardini; Martìn H Devoto; J Oscar Croxatto
Journal:  Curr Opin Ophthalmol       Date:  2008-09       Impact factor: 3.761

  5 in total
  3 in total

1.  Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma.

Authors:  Rui Liu; Nan Wang; Hong Zhang; Xin Ge; Jian-Min Ma
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

2.  A benign presentation of primary ductal adenocarcinoma of lacrimal gland: A rare malignancy.

Authors:  Lindfay Laura Lau; Chong Ka Lung; Syed Shoeb Ahmad
Journal:  Indian J Ophthalmol       Date:  2015-11       Impact factor: 1.848

3.  Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy.

Authors:  Prashanth Ashok Kumar; Shweta Paulraj; Kanish Mirchia; Seung Shin Hahn; Abirami Sivapiragasam
Journal:  Case Rep Oncol Med       Date:  2020-02-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.